Updates on our COVID-19 Vaccines
Sanofi Oncology: Looking Ahead
We asked Peter Adamson, Global Head of Oncology Development at Sanofi, to reflect on an extraordinary year and share his outlook for 2021
Full-Year 2020 Results & Capital Markets Day
The Q4 and full year 2020 results presentation and a strategy update at Capital Markets Day are available
Inspired by Rare Disease Patients Around the World
More than 300 million people worldwide live with a rare disease, often feeling invisible and misunderstood. Find out how they are making a difference in the rare disease community
Sanofi’s Access to Healthcare Recognized in the ATM index
Sanofi takes a place in the top five companies of the 2021 Access to Medicine index
A Two Decades-Long Fight Against Neglected Tropical Diseases
For the World Neglected Tropical Diseases Day, Sanofi celebrates the 20-year collaboration with WHO
-
Press releases2021-02-26MMMM DD YYYYCHMP recommends approval of Sarclisa® (isatuximab) in combination with carfilzomib and dexamethasone for the treatment of relapsed multiple myeloma